Solid Biosciences
SLDB
35 hedge funds and large institutions have $85.3M invested in Solid Biosciences in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 29 closing their positions.
4,220% more call options, than puts
Call options by funds: $216K | Put options by funds: $5K
199.29% more ownership
Funds ownership: 3.75% → 203.04% (+199%)
156% more capital invested
Capital invested by funds: $33.4M → $85.3M (+$51.9M)
40% less funds holding
Funds holding: 58 → 35 (-23)
41% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 17
76% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$17.1M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$17.1M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$17.1M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$9.3M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$5.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
-$4.2M |
| 2 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$373K |
| 3 |
BlackRock
New York
|
-$296K |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$187K |
| 5 |
Renaissance Technologies
New York
|
-$103K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IIA
51
IPG Investment Advisors
San Diego,
California
| – | -$8.35K | -1,193 | Closed |
|
|
NDSI
52
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
| – | -$7 | -1,002 | Closed |
|
|
TP
53
Tranquility Partners
Brentwood,
Tennessee
| – | -$7K | -1,000 | Closed |
|
|
VF
54
Virtu Financial
New York
| – | -$7K | -945 | Closed |
|
55
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$5K | -721 | Closed |
|
|
RPCA
56
Running Point Capital Advisors
El Segundo,
California
| – | -$5K | -667 | Closed |
|
57
BNP Paribas Financial Markets
Paris,
France
| – | -$1.44K | -206 | Closed |
|
|
GTAM
58
Global Trust Asset Management
West Palm Beach,
Florida
| – | -$1K | -167 | Closed |
|
59
Fidelity Investments
Boston,
Massachusetts
| – | -$1K | -153 | Closed |
|
60
Citigroup
New York
| – | -$1K | -98 | Closed |
|
|
CAL
61
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | -$1K | -93 | Closed |
|
62
Osaic Holdings
Scottsdale,
Arizona
| – | -$7 | -1 | -3% |
|
SLDB Hedge Fund Activity: Q4 2022 in Review
35 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q4 2022, worth a combined $85.3M — up 156% from $33.4M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of SLDB and 7 opened new positions — a net loss of 22 holders — while 17 trimmed existing stakes and 10 added.
The largest buyer was Perceptive Advisors, adding an estimated $17.1M. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $4.2M sold.
- 35 institutional investors held Solid Biosciences (SLDB) as of Q4 2022, down from 58 in Q3 2022.
- Funds reported $85.3M of Solid Biosciences stock for Q4 2022, up 156% quarter-over-quarter.
- 7 funds opened new Solid Biosciences positions in Q4 2022 and 29 closed out, a net change of -22 holders.
- The largest Solid Biosciences buyer in Q4 2022 was Perceptive Advisors, an estimated $17.1M added.
- The largest Solid Biosciences seller in Q4 2022 was Suvretta Capital Management, an estimated $4.2M sold.
Based on aggregated 13F filings for Q4 2022.